Secondary Logo

Journal Logo

CON

Perioperative Goal-Directed Fluid Therapy Is an Essential Element of an Enhanced Recovery Protocol?

Joshi, Girish P., MBBS, MD, FFARCSI; Kehlet, Henrik, MD, PhD

doi: 10.1213/ANE.0000000000001233
Editorials: Editorial
Free

From the *Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas; and Section for Surgical Pathophysiology, Rigshospitalet Copenhagen University, Copenhagen, Denmark.

Accepted for publication January 19, 2016.

Funding: None.

The authors declare no conflicts of interest.

Reprints will not be available from the authors.

Address correspondence to Girish P. Joshi, MBBS, MD, FFARCSI, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390. Address e-mail to girish.joshi@utsouthwestern.edu.

Perioperative fluid therapy is one of the major factors that influences postoperative outcome after major abdominal surgery.1–3 Undetected (i.e., subclinical) hypovolemia and hypervolemia are associated with increased perioperative complications and prolonged hospital stay.1–3 Fluid therapy remains one of the most controversial aspects of perioperative care. There is continuing debate with regard to the quantity and the type of fluid resuscitation during elective major surgery. Recent evidence suggests that judicious perioperative fluid therapy improves outcomes after major elective gastrointestinal surgery.1–3

Goal-directed fluid therapy (GDFT), assessed by an optimized cardiac stroke volume, has been proposed as the “gold standard” for perioperative fluid therapy. GDFT has been shown to reduce perioperative complications and shorten length of hospital stay.1–3 In fact, GDFT is considered an essential element of enhanced recovery after surgery (ERAS) protocols.4 However, we question whether GDFT is a uniformly essential element of the ERAS protocol. As we will explain below, the systematic reviews and meta-analyses that have concluded that it improves postoperative outcome including morbidity and hospital length of stay are fraught with flaws.5 Furthermore, most of the evidence suggesting the benefits of GDFT comes from studies without the implementation of ERAS programs. Extrapolating evidence from one setting (i.e., non-ERAS) to another (i.e., ERAS program) can be misleading and result in inappropriate patient care.

Back to Top | Article Outline

CURRENT CONTROVERSIES REGARDING GDFT

The randomized controlled trials included in several systematic reviews and meta-analyses suggesting the benefits of GDFT have significant heterogeneity.5,6 For example, the definitions of “standard” fluid therapy and GDFT varied considerably, as did the triggers for fluid bolus administration. Although most studies evaluating GDFT have used stroke volume to optimize intravascular volume, other goals included dynamic hemodynamic variables (e.g., cardiac output, cardiac index, and oxygen delivery index) and static hemodynamic variables (e.g., mean arterial blood pressure and urine output). Several of these studies, particularly the older ones, did not include individual optimization of hemodynamic goals such as fluid administration based on fluid responsiveness but used prefixed goals such as achieving a predetermined amount of oxygen delivery or a predetermined cardiac output, which may not be applicable to all patients.5 Some studies used only fluid administration, whereas others used combinations of fluids and vasoactive drugs (e.g., dobutamine and dopexamine).

The studies also varied in the fluid bolus volume and the type of fluids administered.7 A recent study reported wide variability in crystalloid administration within and between individual providers.8 The authors conclude that the use of specific protocols (i.e., GDFT) may reduce variation among providers. However, even the studies evaluating GDFT have reported a wide variation in the amount of fluids administered.8 Several studies reported a larger amount of fluids administered in the GDFT group compared with the standard of care group.9

The other area of variability includes the monitors used to guide fluid therapy. These include esophageal Doppler monitoring, calibrated pulse contour analyses monitor, and bioreactance-based noninvasive cardiac output monitor. Because there is poor agreement among monitors,10,11 they are not interchangeable with regard to hemodynamic optimization within a GDFT protocol.11

The definitions of postoperative complications among the studies included in systematic reviews and meta-analyses vary significantly. Many studies have used composite morbidity as the primary end point although the combinations of complications including the definition of morbidity vary significantly. Most importantly, the types of complications assessed in many studies were not always the consequences of perioperative fluid management, but rather the measures of competent patient care.5

Some studies included variable approaches to abdominal surgery (i.e., open and laparoscopic approaches). Pain management protocols varied, and the most consequential of which being the variability in the use of epidural analgesia, which will influence fluid requirements. Even among the subjects receiving epidural analgesia, some had thoracic epidurals, whereas others had lumbar epidurals.12

Finally, the majority of the studies assessing GDFT did not include the ERAS principles as a part of the perioperative care.13 Therefore, it is not surprising that the length of hospital stays in the studies do not reflect the length of stay in current ERAS clinical practice.5

The authors of several meta-analysis concluded that the large heterogeneity among current studies could only be resolved with large prospective clinical trials.6 A recent large (n = 734) multicenter randomized trial in high-risk patients undergoing major gastrointestinal surgery reported that GDFT did not significantly reduce postoperative complications and 30-day mortality compared with standard care.14 However, these authors supplemented their negative findings with previous data in a flawed meta-analysis5 that supported the use of GDFT.14 Another recent study also concluded that GDFT did not reduce overall postsurgical morbidity or length of stay after major abdominal surgery.12

Back to Top | Article Outline

GOAL-DIRECTED PERIOPERATIVE FLUID THERAPY IN THE ERAS SETTING

The ERAS or fast-track concept involves implementation of multimodal, multidisciplinary perioperative care pathways designed to reduce perioperative organ dysfunction and morbidity. These pathways foster early ambulation and reduce hospital length of stay.15 Evidence suggests that implementation of the ERAS protocols improves perioperative outcomes and reduces health care costs.16 The elements of an optimal ERAS program for major abdominal surgery include minimally invasive surgery (i.e., a laparoscopic approach); avoidance of mechanical bowel preparation; avoidance of overloading with fluids before administration of epidural analgesia (or preferably avoidance of epidural analgesia17); GDFT; aggressive postoperative nausea, vomiting, and pain prophylaxis; limitation of intraoperative and postoperative opioids by using nonopioid analgesics,18 and avoidance of unnecessary drains and catheters.19 Implementation of these practices reduces postoperative complications such as ileus, nausea, and vomiting; accelerates resumption of enteral feeding; and promotes early mobilization.5

Perioperative fluid requirements depend on multiple factors, including the patient’s preoperative intravascular volume status, preoperative comorbidities, anesthetic technique, and nature of the surgery. The above-mentioned elements included in the ERAS protocol can also influence perioperative fluid balance. Fluid requirements and pathogenesis of morbidity are procedure specific. Minimal access or laparoscopic surgical approaches minimize physiological stress response and blood loss as well as reduce postoperative pain and opioid requirements. These reduce perioperative fluid shifts and fluid requirements20 while also reducing postoperative complications. Similarly, avoidance of mechanical bowel preparation and adequate preoperative fluid intake during the fasting period including preoperative carbohydrate loading avoid preoperative dehydration. Thus, patients are less likely to be volume-depleted preoperatively.

Several ERAS recommendations should reduce intravascular volume overload and thus eliminate the need for GDFT. For example, ERAS protocols recommend elimination of fluid preload before epidural analgesia, which should limit intraoperative fluid administration without encountering intraoperative hemodynamic instability and thus avoid fluid overload.21 Similarly, the avoidance of deep general anesthesia is recommended, which would reduce the need for higher fluid administration to maintain adequate hemodynamics and avoid fluid overload. Also, use of lung-protective ventilation with lower tidal volumes, which has become the standard of care,22 further minimizes hemodynamic changes observed with the use of larger tidal volumes and thus limits intraoperative fluid administration.

Although epidural analgesia has been shown to provide excellent pain relief, reduce opioid requirements, and attenuate the surgical stress response, optimal multimodal analgesic techniques with nonopioid analgesics combined with regional analgesia such as surgical-site local anesthetic infiltration have been shown to provide adequate pain relief with similar postoperative outcomes.17,18 Furthermore, epidural analgesia may induce orthostatic hypotension and limb weakness, which may delay ambulation. In fact, a recent analysis of the international, multicenter ERAS registry data found that epidural analgesia was associated with increased length of hospital stay.23 Avoidance of epidural analgesia and associated sympathectomy may limit fluid administration and the potential for fluid overload. One of the important elements of the ERAS program is early resumption of enteral feeding and early mobilization as well as avoidance of tubes and drains, which should allow improved postoperative fluid and nutritional balance.

Given the above-mentioned considerations, fluid therapy in patients within the ERAS pathway should be different from those in the non-ERAS practice. Current evidence suggests that GDFT was more effective outside the ERAS program,9,24 but less effective in an ERAS program, as demonstrated by double-blind randomized multicenter trials in patients undergoing elective colorectal surgery.25,26 Another randomized controlled trial found that the use of GDFT to optimize stroke volume offered no significant benefit with respect to postoperative outcome over fluid therapy using a “zero balance” strategy (i.e., replace only the fluid that is lost during surgery) and maintaining postoperative normal body weight.21 A carefully monitored perioperative zero balance approach may be adequate in the context of ERAS, obviating the need for GDFT.

Obviously, patients with significant comorbidities may benefit from more intense hemodynamic monitoring, but such practice would be a component of optimal anesthesia care for all types of surgical procedures, and not limited to abdominal surgical procedures.

Back to Top | Article Outline

CONCLUSIONS

Despite the significant evidence demonstrating the benefits of GDFT, there is no clear consensus about the most effective goals or the most appropriate monitoring device for guiding therapy. Several confounding factors that hinder conclusive evidence for routine use of perioperative GDFT include ERAS programs not implemented, different technologies used for GDFT, different goals for GDFT, different GDFT protocols (fluid volume), different procedures with different fluid pathophysiology, limited data on postoperative GDFT, and limited data in specific high-risk patients. This heterogeneity has led to confusion among practitioners about which GDFT algorithm and device should be used in clinical practice. Because an optimal ERAS protocol may reduce the risk of perioperative fluid imbalance, the value of GDFT may be less in ERAS programs than in programs that do not implement ERAS principles. We submit that the “routine” use of GDFT is not only questionable, but may also lead to increased costs, inappropriate patient care, and unintended consequences.

Back to Top | Article Outline

DISCLOSURES

Name: Girish P. Joshi, MBBS, MD, FFARCSI.

Contribution: This author helped write the manuscript.

Attestation: Girish P. Joshi approved the final version of the manuscript.

Name: Henrik Kehlet, MD, PhD.

Contribution: This author helped write the manuscript.

Attestation: Henrik Kehlet approved the final version of the manuscript.

This manuscript was handled by: Steven L. Shafer, MD.

Back to Top | Article Outline

REFERENCES

1. Srinivasa S, Hill AG. Perioperative fluid administration: historical highlights and implications for practice. Ann Surg. 2012;256:1113–8
2. Suehiro K, Joosten A, Alexander B, Cannesson M. Guiding goal-directed therapy. Curr Anesthesiol Rep. 2014;4:360–75
3. Miller TE, Raghunathan K, Gan TJ. State-of-the-art fluid management in the operating room. Best Pract Res Clin Anaesthesiol. 2014;28:261–73
4. Gustafsson UO, Scott MJ, Schwenk W, Demartines N, Roulin D, Francis N, McNaught CE, Macfie J, Liberman AS, Soop M, Hill A, Kennedy RH, Lobo DN, Fearon K, Ljungqvist O. Guidelines for perioperative care in elective colonic surgery: enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg. 2013;37:259–84
5. Kehlet H, Joshi GP. Systematic reviews and meta-analyses of randomized controlled trials on perioperative outcomes: an urgent need for critical reappraisal. Anesth Analg. 2015;121:1104–7
6. Benes J, Giglio M, Brienza N, Michard F. The effects of goal-directed fluid therapy based on dynamic parameters on post-surgical outcome: a meta-analysis of randomized controlled trials. Crit Care. 2014;18:584 doi: 10.1186/s13054-014-0584-z
7. Yates DR, Davies SJ, Milner HE, Wilson RJ. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. Br J Anaesth. 2014;112:281–9
8. Lilot M, Ehrenfeld JM, Lee C, Harrington B, Cannesson M, Rinehart J. Variability in practice and factors predictive of total crystalloid administration during abdominal surgery: retrospective two-centre analysis. Br J Anaesth. 2015;114:767–76
9. Gómez-Izquierdo JC, Feldman LS, Carli F, Baldini G. Meta-analysis of the effect of goal-directed therapy on bowel function after abdominal surgery. Br J Surg. 2015;102:577–89
10. Waldron NH, Miller TE, Thacker JK, Manchester AK, White WD, Nardiello J, Elgasim MA, Moon RE, Gan TJ. A prospective comparison of a noninvasive cardiac output monitor versus esophageal Doppler monitor for goal-directed fluid therapy in colorectal surgery patients. Anesth Analg. 2014;118:966–75
11. Feldheiser A, Hunsicker O, Krebbel H, Weimann K, Kaufner L, Wernecke KD, Spies C. Oesophageal Doppler and calibrated pulse contour analysis are not interchangeable within a goal-directed haemodynamic algorithm in major gynaecological surgery. Br J Anaesth. 2014;113:822–31
12. Pestaña D, Espinosa E, Eden A, Nájera D, Collar L, Aldecoa C, Higuera E, Escribano S, Bystritski D, Pascual J, Fernández-Garijo P, de Prada B, Muriel A, Pizov R. Perioperative goal-directed hemodynamic optimization using noninvasive cardiac output monitoring in major abdominal surgery: a prospective, randomized, multicenter, pragmatic trial: POEMAS Study (PeriOperative goal-directed thErapy in Major Abdominal Surgery). Anesth Analg. 2014;119:579–87
13. Srinivasa S, Lemanu DP, Singh PP, Taylor MH, Hill AG. Systematic review and meta-analysis of oesophageal Doppler-guided fluid management in colorectal surgery. Br J Surg. 2013;100:1701–8
14. Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, Ahern A, Griggs K, Scott R, Hinds C, Rowan KOPTIMISE Study Group. OPTIMISE Study Group. . Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311:2181–90
15. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth. 1997;78:606–17
16. Lee L, Mata J, Ghitulescu GA, Boutros M, Charlebois P, Stein B, Liberman AS, Fried GM, Morin N, Carli F, Latimer E, Feldman LS. Cost-effectiveness of enhanced recovery versus conventional perioperative management for colorectal surgery. Ann Surg. 2015;262:1026–33
17. Joshi GP, Bonnet F, Kehlet HPROSPECT Collaboration. PROSPECT Collaboration. . Evidence-based postoperative pain management after laparoscopic colorectal surgery. Colorectal Dis. 2013;15:146–55
18. Joshi GP, Schug SA, Kehlet H. Procedure-specific pain management and outcome strategies. Best Pract Res Clin Anaesthesiol. 2014;28:191–201
19. Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg. 2008;248:189–98
20. Li MZ, Xiao LB, Wu WH, Yang SB, Li SZ. Meta-analysis of laparoscopic versus open colorectal surgery within fast-track perioperative care. Dis Colon Rectum. 2012;55:821–7
21. Brandstrup B, Svendsen PE, Rasmussen M, Belhage B, Rodt SÅ, Hansen B, Møller DR, Lundbech LB, Andersen N, Berg V, Thomassen N, Andersen ST, Simonsen L. Which goal for fluid therapy during colorectal surgery is followed by the best outcome: near-maximal stroke volume or zero fluid balance? Br J Anaesth. 2012;109:191–9
22. Güldner A, Kiss T, Serpa Neto A, Hemmes SN, Canet J, Spieth PM, Rocco PR, Schultz MJ, Pelosi P, Gama de Abreu M. Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers. Anesthesiology. 2015;123:692–713
23. ERAS Compliance Group. . The impact of enhanced recovery protocol compliance on elective colorectal cancer resection: results from an international registry. Ann Surg. 2015;261:1153–9
24. Minto G, Scott MJ, Miller TE. Monitoring needs and goal-directed fluid therapy within an enhanced recovery program. Anesthesiol Clin. 2015;33:35–49
25. Srinivasa S, Taylor MH, Singh PP, Yu TC, Soop M, Hill AG. Randomized clinical trial of goal-directed fluid therapy within an enhanced recovery protocol for elective colectomy. Br J Surg. 2013;100:66–74
26. Phan TD, D’Souza B, Rattray MJ, Johnston MJ, Cowie BS. A randomised controlled trial of fluid restriction compared to oesophageal Doppler-guided goal-directed fluid therapy in elective major colorectal surgery within an Enhanced Recovery After Surgery program. Anaesth Intensive Care. 2014;42:752–60
© 2016 International Anesthesia Research Society